Ames Salmonella/mammalian-microsome testing of peptides and peptide synthesis reagents

Area of Science:

• Biochemistry and Molecular Biology
• Toxicology
• Chemical Safety

Background:

• Peptide synthesis involves various chemical reagents, some of which may pose safety risks.
• Evaluating the mutagenicity of these reagents is crucial for ensuring safe laboratory practices and product development.

Purpose of the Study:

• To assess the bacterial mutagenicity of bioactive peptides and chemical reagents used in peptide synthesis.
• To identify any potentially hazardous reagents that could pose a risk to researchers or consumers.

Main Methods:

• Utilized the Ames Salmonella/mammalian-microsome assay, a standard method for detecting bacterial mutagenicity.
• Tested six bioactive peptides and eleven chemical reagents involved in peptide synthesis.
• Examined mutagenic activity across multiple bacterial strains (TA100, TA1535, TA1537).

Main Results:

• Two reagents, bis(2-oxo-3-oxazolidinyl)phosphinic chloride and fluoren-9-ylmethyl chloroformate, exhibited mutagenic activity.
• Mutagenicity was observed with specific bacterial strains: TA100 and TA1535 for the first reagent, and TA1537 for the second.
• No mutagenic activity was detected in any of the six bioactive peptides or the remaining nine synthesis reagents.

Conclusions:

• Bis(2-oxo-3-oxazolidinyl)phosphinic chloride and fluoren-9-ylmethyl chloroformate are identified as potential mutagens.
• Bioactive peptides and the majority of tested synthesis reagents appear safe concerning bacterial mutagenicity.
• Highlights the importance of mutagenicity testing for chemical reagents in peptide synthesis.